Companies
Companies
Swiss Vaccine Developer Wins $22m Grant to Tackle Global Gonorrhea Crisis
🔬 Swiss vaccine developer LimmaTech Biologics AG receives $2.2m grant from CARB-X to fight Neisseria gonorrheae. 💉
Revolutionary Cell-Therapy Tech: Scalability Made Simple
🔍 MFX is revolutionizing cell therapy manufacturing with its scalable Cyto Engine Stack, securing funding for a 2025 release. 🧪📈💰🔬
BMS to Build $400M Biologics Facility in Dublin Boosting Manufacturing Capacity
📢 Bristol Myers Squibb (BMS) invests $400M in a new sterile drug product facility in Dublin, Ireland. 🌍💪🧪🔬 Expected completion: 2026.
Curve Therapeutics Secures £405m in Funding to Revolutionize Cancer Treatment
📢 Curve Therapeutics secures £40.5m in funding led by Pfizer Ventures to advance cancer target screening and peptide pipeline! 💪🔬
The High Costs of Low-Quality Albumin: Risks and Solutions
1. 🚫💉 The Hidden Costs of Sub-standard Recombinant Albumin: Lost batches and patient risks in vaccines and biopharmaceuticals. 💰💊 2. The Hidden Costs of Sub-standard Recombinant Albumin: Safely lowering prices and broadening access to premium albumin. 💡💉🌾🔬🔍
Genezen Revolutionizes Vector Production with CSL Licensing
📢 Genezen becomes first CDMO to license CSL's Cytegrity system, helping to alleviate viral vector shortage and improve quality. 🚀👩🔬💊
Price and Time Barriers for Amtagvi Rollout
📢 Iovance struggles with price and time constraints hindering the Amtagvi rollout. Read more on our home page! 🏠
CDMO Incog Supercharges Operations with $75M Expansion
🔧 CDMO Incog gears up with 💰$75m expansion to boost filling capacity. Exciting times ahead! 🚀🔬👩🔬 pharmaceuticals growth
Firefly Raises $94 Million to Revolutionize Cancer Treatment
🔥 Firefly secures $94m 💼 to develop antibody conjugates ⚡️ for precision medicines targeting cancer and other diseases. 🌍
Gene Therapy Supplier Raises £7M for Breakthrough Technology
💰 Gene therapy supplier MIP Discovery secures £7M in funding to boost commercialization of synthetic affinity reagents in cell and gene therapy. 🧬🔬👥
